BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 25740672)

  • 1. Topical timolol solution versus laser in treatment of infantile hemangioma: a comparative study.
    Tawfik AA; Alsharnoubi J
    Pediatr Dermatol; 2015; 32(3):369-76. PubMed ID: 25740672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study.
    Ma G; Wu P; Lin X; Chen H; Hu X; Jin Y; Qiu Y
    Pediatr Dermatol; 2014; 31(3):286-91. PubMed ID: 24602019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical study of Timolol Maleate Eye Drops for the treatment of superficial infantile hemangiomas].
    Linjun Y; Jiachuan X; Baoli S; Qixing X; Chunfen L
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2015 Nov; 31(6):440-5. PubMed ID: 27055324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Two Formulations of Topical Timolol for the Treatment of Infantile Hemangiomas.
    Ng MSY; Tay YK; Ng SS; Foong AYW; Koh MJ
    Pediatr Dermatol; 2017 Jul; 34(4):492-493. PubMed ID: 28543755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical timolol maleate for superficial infantile hemangiomas: an observational study.
    Xu DP; Cao RY; Tong S; Xue L; Sun NN; Wang XK
    J Oral Maxillofac Surg; 2015 Jun; 73(6):1089-94. PubMed ID: 25843815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managment of superficial infantile capillary hemangiomas with topical timolol maleate solution.
    Rizvi SA; Yusuf F; Sharma R; Rizvi SW
    Semin Ophthalmol; 2015 Jan; 30(1):62-4. PubMed ID: 24074395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study.
    Chakkittakandiyil A; Phillips R; Frieden IJ; Siegfried E; Lara-Corrales I; Lam J; Bergmann J; Bekhor P; Poorsattar S; Pope E
    Pediatr Dermatol; 2012; 29(1):28-31. PubMed ID: 22150436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective, open-label, rater-blinded and self-controlled pilot study of the treatment of proliferating superficial infantile hemangiomas with 0.5% topical timolol cream versus 595-nm pulsed dye laser.
    Ying H; Zou Y; Yu W; Qiu Y; Ma G; Chang L; Gu Y; Lyu D; Lin X
    J Dermatol; 2017 Jun; 44(6):660-665. PubMed ID: 28191657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
    Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
    Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical timolol 0.5% gel-forming solution for small deep facial infantile hemangiomas.
    Sorrell J; Chamlin SL
    Pediatr Dermatol; 2013; 30(5):592-4. PubMed ID: 23889228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical timolol for small hemangiomas of infancy.
    Moehrle M; Léauté-Labrèze C; Schmidt V; Röcken M; Poets CF; Goelz R
    Pediatr Dermatol; 2013; 30(2):245-9. PubMed ID: 22471694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled study of topical 0.25% timolol maleate gel for the treatment of cutaneous infantile capillary hemangiomas.
    Chambers CB; Katowitz WR; Katowitz JA; Binenbaum G
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):103-6. PubMed ID: 22410658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infantile Hemangioma: Clinical Characteristics and Efficacy of Treatment with the Long-Pulsed 1,064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser in 794 Chinese Patients.
    Zhong SX; Tao YC; Zhou JF; Liu YY; Yao L; Li SS
    Pediatr Dermatol; 2015; 32(4):495-500. PubMed ID: 25950113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractional 2940-nm Er:YAG laser-assisted drug delivery of timolol maleate for the treatment of deep infantile hemangioma.
    Sun L; Wang C; Cao Y; Lv X; Tian L; Liu D; Li L; Zhao W
    J Dermatolog Treat; 2021 Dec; 32(8):1053-1059. PubMed ID: 32043380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption.
    Weibel L; Barysch MJ; Scheer HS; Königs I; Neuhaus K; Schiestl C; Rentsch K; Müller DM; Theiler M
    Pediatr Dermatol; 2016; 33(2):184-90. PubMed ID: 26840644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
    Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
    Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
    Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
    JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
    Ge J; Zheng J; Zhang L; Yuan W; Zhao H
    Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions.
    Li G; Xu DP; Tong S; Xue L; Sun NN; Wang XK
    J Craniofac Surg; 2016 Jan; 27(1):56-60. PubMed ID: 26716547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectral Doppler ultrasound for predicting long-term response to topical timolol in children with infantile hemangioma.
    He L; Huang G
    J Clin Ultrasound; 2017 Oct; 45(8):480-487. PubMed ID: 28369943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.